Skip to main content
MDGL logo

MDGL · Madrigal Pharmaceuticals, Inc. · Holdings

Track MDGL — free
$379.10 -17.64 (-4.45%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$8.81B
Shares
23.23M
Volume · Nov 20 327.92K Avg daily vol (3M) 367.24K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 448
Total Value: $11,106,275,210
Total Shares: 22,038,011
+ 213,886 shares withheld under SEC confidential treatment, last reported; not in the totals
Showing 1–100 of 470 holdings by value · page 1 of 5

Institutional Ownership Trend

27 quarters

A holder reported that quarter and withheld its positions under SEC confidential treatment, which is not a sale. The line counts it at the shares it last reported; filers usually disclose the real figures about a year later.

Holder Concentration

Share of 13F common-share value, across 448 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
9.7%
Dec 2023 → Sep 2026 · range 9.0% – 14.7%
+0.6 pts
Top 5
39.4%
Dec 2023 → Sep 2026 · range 39.2% – 48.3%
+0.2 pts
Top 10
56.5%
Dec 2023 → Sep 2026 · range 56.5% – 71.5%
−0.4 pts
HHI
416
Dec 2023 → Sep 2026 · range 415 – 609
Broadly held+1

Who Holds MDGL

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 442 filers, like-for-like change -6.4%; actively managed books -7.7%; index-like books -0.9%.

Holder type Share Filers Change
Registered adviser 52.1% 235 -10.1%
Exempt adviser 1.0% 4 +52.1%
Adviser 19.3% 11 +19.5%
Bank 6.4% 25 -10.9%
Insurer 0.0% 2 -69.2%
Broker-dealer 0.1% 3 -82.2%
Benefit plan 0.2% 6 +5.3%
Non-US 2.1% 12 +2.5%
Holding company 12.8% 9 -1.7%
Unknown 6.0% 135 -15.3%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 3 holders with no observed 2026-06-30 13F and 6 holders with no observed 2026-09-30 13F.

Conviction and Crowding

442 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
7
1.58% of filers hold it in their top 10
Jun 30, 2026: 9
Holders above 5%
3
median weight 0.007%
Jun 30, 2026: 5
Crowding
41.0%
of shares outstanding, 92nd percentile
Private-fund advisers
39.8%
of shares outstanding
Institutional ownership
95.4%
107.6% of the estimated free float above 100%: filers can report lent or client shares more than once
Top 10 holders
56.5%
of 13F shares, Herfindahl 0.042
Active holders
-7.7%
like-for-like share change of active filers
5% stakes on record
7
3 13D, 4 13G (3 institutional, 1 passive, 0 exempt)
How long holders have held it value-weighted 16.3 quarters
Under 1 year 13.6% 1 to 3 years 23.2% 3 years or more 63.2% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $821,230,223 (16 buying, 15 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$394.23
estimated per share
Jun 30, 2026: $341.75
Quarter-end price
$503.96
implied by 13F values
Estimated gain or loss
+27.8%
price against the estimated cost
Estimated at a loss
30.9%
of costed 13F value

Estimated cost covers 41.3% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies MDGL's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 CYTK Cytokinetics Inc 15
2 PRAX Praxis Precision Medicines, Inc. 13
3 RVMD Revolution Medicines, Inc. 22
4 ELVN Enliven Therapeutics, Inc. 11
5 IMVT Immunovant, Inc. 8
6 PTCT Ptc Therapeutics, Inc. 8
7 ERAS Erasca, Inc. 10
8 IDYA IDEAYA Biosciences, Inc. 8
9 PRLD Prelude Therapeutics Inc 4
10 TNGX Tango Therapeutics, Inc. 11

Shareholder Targets

13F filers that own its peers but not MDGL, quarter ended Sep 30, 2026

Found through its holder-overlap peers: CYTK, PRAX, RVMD, ELVN, IMVT, PTCT, ERAS, IDYA, PRLD, TNGX, INSM, DNTH, SYRE, RYTM, XENE, LTGO, CLDX, DFTX, TSHA, TVTX. 924 filers in all.

# Filer In peers
1 FARALLON CAPITAL MANAGEMENT LLC Registered adviser, Diversified active $3,112,993,513 5 held
2 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $2,617,220,340 8 held
3 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $2,272,088,844 5 held
4 Darwin Global Management, Ltd. Exempt adviser, Concentrated $2,181,877,263 1 held
5 Capital World Investors Adviser, Diversified active $1,839,473,446 7 held
6 Nextech Invest, Ltd. Exempt adviser, Concentrated $1,560,199,117 1 held
7 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $1,529,216,566 8 held
8 Capital International Investors Adviser, Diversified active $1,335,506,509 5 held
9 Orbis Allan Gray Ltd Unknown, Diversified active $1,278,638,805 3 held
10 ADAGE CAPITAL PARTNERS GP, L.L.C. Registered adviser, Diversified active $1,224,511,960 12 held

Fund Ownership of MDGL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 13.54% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.44% 566,002
Index ETFs 11.10% 2,578,620
Active ETFs 0.26% 60,393
Active funds 16.19% 3,761,476
Unclassified 0.31% 72,976
All registered funds 30.30% 7,039,467
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
78
Increased
164
Decreased
135
Sold Out
49
Unchanged
68

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +26
Institutional value: -12.3%
Shares held: -6.6%

Institutional value and shares held compare the totals as filed: 213,886 shares reported for Jun 30, 2026 by holders that withheld this quarter are left out, and that part of the change is not a sale.

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 470
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 470 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1157601 CUSIP 558868105 13F (30d) 432 filings 393 filers Visit website Investor relations